Pathwork Diagnostics announced this week the appointment of Fletcher Payne as its new chief financial officer and Mark McDonough as its VP of US sales
Payne joins Pathwork from Plexxikon, a biopharmaceutical company where he served as a VP and CFO. Before Plexxikon, Payne held various posts at Rinat Neuroscience, Dynavax Technologies, Cell Genesys, Sun Microsystems, and IBM.
McDonough joins Pathwork from US Labs, a division of Laboratory Corporation of America. He has also held sales and sales management roles at Ventana Medical Systems and served as a navigator and communications officer in the United States Navy.
Roger Schultz has joined Signature Genomic Laboratories as a laboratory director.
Schultz was previously associate director of cytogenetics of Veripath Laboratories at the University of Texas Southwestern. He holds a PhD in genetics from Michigan State University and completed a postdoc at Stanford University School of Medicine.
Thomas O'Connor has been appointed senior vice president of sales and marketing at SQI Diagnostics.
He will be based in the US and will be responsible for building SQI's multiplex immunoassay platform franchise in North America and Europe, the Toronto-based company said.
O'Connor has held executive sales positions at Luminex, Beckman Coulter, and Exagen Diagnostics.